This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mbow, M. L.
Right arrow Articles by Titus, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mbow, M. L.
Right arrow Articles by Titus, R. G.

 Previous Article  |  Next Article 

Infection and Immunity, October 1999, p. 5470-5472, Vol. 67, No. 10
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

An OspC-Specific Monoclonal Antibody Passively Protects Mice from Tick-Transmitted Infection by Borrelia burgdorferi B31

M. Lamine Mbow,1,* Robert D. Gilmore Jr.,2 and Richard G. Titus1

Department of Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University,1 and Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services,2 Fort Collins, Colorado

Received 31 March 1999/Returned for modification 11 May 1999/Accepted 21 July 1999


    ABSTRACT
Top
Abstract
Text
References

A murine monoclonal antibody directed against Borrelia burgdorferi B31 outer surface protein C (OspC) antigen was generated by a method whereby borreliae were inoculated into the mouse via the natural transmission mode of tick feeding. Passive immunization with this antibody resulted in protection of C3H/HeJ and outbred mice from a tick-transmitted challenge infection. Immunofluorescence staining of borrelia cells indicated surface exposure of the OspC epitope reactive with the monoclonal antibody.


    TEXT
Top
Abstract
Text
References

The outer surface protein C (OspC) of Borrelia burgdorferi, the causative agent of Lyme disease, elicits a protective immune response against infection in animals which have been actively immunized with the recombinant antigen (4, 9, 10). Anti-OspC activity in polyclonal serum samples from B. burgdorferi-infected, immune hosts has been implicated in protection (6, 7). Also, a polyclonal, monospecific anti-recombinant OspC has shown therapeutic properties when passively administered to chronically infected subjects (14). To our knowledge, however, no monoclonal antibodies (MAbs) against OspC have been documented to demonstrate protection upon passive transfer. This laboratory generated a panel of MAbs derived from a tick-borne B. burgdorferi antigen introduction method, rather than using an inoculum of borrelial antigens obtained from in vitro-cultivated organisms (5). One of these MAbs was directed against OspC. The present study was performed to determine if this anti-OspC MAb would passively protect experimental mice.

The generation of the MAb panel has been described elsewhere (5). Briefly, B. burgdorferi-infected nymphal ticks were allowed to feed on 8- to 12-week-old female BALB/cByJ mice. Infection of the mice with B. burgdorferi was confirmed by positive cultures derived from ear biopsy specimens (12). The mice were reinfested with B. burgdorferi-infected ticks 1 month later. At the end of this immunization schedule, serum samples were analyzed by enzyme-linked immunosorbent assay (ELISA) against B. burgdorferi whole-cell lysate, and the mouse with the highest titer was selected for hybridoma production. Three days before the cell fusion procedure, 105 strain B31 low-passage-number organisms (passage 1, cultured from ticks) were injected intravenously. This boost served to enhance existing, primed B-cell polyclonal populations prior to spleen harvesting, but only those populations common to antigens expressed in both cultured and tick-transmitted B. burgdorferi. Spleen cells were harvested and fused with cP3x63-Ag8.653 myeloma cells by use of polyethylene glycol 1000. The spleen cell/myeloma cell ratio was approximately 5:1. Fused cells were selected by using medium containing hypoxanthine-aminopterin-thymidine. Wells were screened by ELISA and Western blotting with low-passage-number B. burgdorferi B31 as the antigen. Cells from positive wells were expanded and cloned by limited dilution. The OspC specificity of one of the MAbs was determined by its immunoblot reactivity against recombinant OspC, and it was designated B5 (Fig. 1). MAb B5 was isotyped as an immunoglobulin G2a (IgG2a).


View larger version (51K):
[in this window]
[in a new window]
  		FIG. 1.   Western blot demonstrating MAb B5 reactivity against OspC antigens. Lanes: 1, B. burgdorferi B31 lysate; 2, lysate from Escherichia coli harboring the plasmid expression vector pBluescript (Stratagene, La Jolla, Calif.) only; 3, E. coli lysate expressing OspC from pBluescript. Molecular mass markers, in kilodaltons, are indicated on the left. The recombinant OspC migrates higher than the B. burgdorferi OspC due to the addition of a vector-encoded fusion partner. MAb B5 was used at a dilution of 1:5,000.

Anti-OspC IgG was purified from ascitic fluid by ammonium sulfate precipitation. Groups of test mice were injected intravenously with 100 µl containing either 200 to 300 µg of the anti-OspC antibody or the same amount of normal mouse IgG 1 day prior to tick infestation. Inbred mice (C3H/HeJ) and outbred mice (specific-pathogen-free mice maintained at the Division of Vector-Borne Infectious Diseases) were used in this study. One day following passive transfer of the antibody, each mouse was infested with 10 B. burgdorferi-infected nymphal Ixodes scapularis ticks, which were allowed to feed to repletion. The B31 strain-infected tick colony has been described previously (8). To assay for infectivity, ear skin biopsy specimens were cultured 4 weeks post-tick feeding as described previously (12); also, serological bleedings were taken between 2 and 4 weeks after tick drop-off and samples were assayed by Western blotting. One positive-control mouse was passively immunized with a polyclonal anti-OspA antibody, which was known to be protective (2, 3).

All mice passively immunized with the anti-OspC MAb were protected from infection (11 of 11), whereas each mouse inoculated with control antibody was not protected (Table 1). Following feeding, replete ticks were randomly collected from the OspC-immunized inbred mice and were surface sterilized (by serial washes in 70% ethanol for 2 min, 3% hydrogen peroxide for 2 min, and sterile water for 2 min), crushed, and inoculated into Barbour-Stoenner-Kelley modified culture medium (BSK II medium). Seven of nine ticks yielded viable borreliae in culture, reflecting the 70 to 80% infection rate of the tick colony. This result ensured that the ticks placed upon the mice were indeed harboring B. burgdorferi. It also corroborated a result previously seen in this laboratory, that a population of borreliae survives within the tick following feeding on OspC-immunized mice (4), unlike borreliae in ticks that feed on OspA-immunized mice (3).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Results of infectivity assay 4 weeks postchallenge

To assess the cell surface accessibility of the antibody, indirect immunofluorescence was performed on cultured B31 organisms as follows. Five microliters of a stationary-phase borrelial culture grown in BSK II medium was allowed to air dry on a microscope slide. The cells were heat fixed by a slight warming of the slide but were not acetone or methanol fixed. The organisms were overlaid with a 1:100 dilution of the anti-OspC B5 antibody and incubated for at least 1 h at room temperature. Following the primary incubation, the slide was washed three times in phosphate-buffered saline (PBS) and allowed to air dry, followed by a secondary incubation with a 1:50 dilution of fluorescein isothiocyanate-conjugated goat anti-mouse IgG (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) for 1 h at room temperature. The slide was washed three times with PBS, allowed to air dry, and overlaid with mounting medium (Kirkegaard & Perry Laboratories) and a coverslip. The finished slide was viewed under a dark-field microscope, and by epifluorescence with a fluorescein filter, at magnification of ×100 and ×400. The nonfixed borreliae fluoresced, indicating surface exposure of the OspC epitope reactive with this antibody (Fig. 2B). In addition, an indirect immunofluorescence assay using a MAb directed against flagellin, a non-surface-exposed antigen, gave a negative signal when nonfixed B. burgdorferi were used (data not shown). Normal mouse serum failed to cause the borrelia cells to fluoresce (Fig. 2D). Surface exposure of OspC epitopes in some B. burgdorferi strains has been speculated to correlate with protective capability (1), and the surface accessibility of the OspC epitope reactive with MAb B5 shown in Fig. 2B is consistent with that observation.


View larger version (102K):
[in this window]
[in a new window]
  		FIG. 2.   Indirect immunofluorescence staining of B. burgdorferi B31 cultured cells labeled with anti-OspC MAb B5 or normal mouse serum. (A) Representative field under dark-field microscopy; (B) the same field as in panel A labeled with anti-OspC MAb B5; (C) a second representative field under dark-field microscopy; (D) the same field as in panel C labeled with normal mouse serum. Magnification, ×400.

This study has demonstrated the protective efficacy of a MAb directed against the B. burgdorferi B31 OspC antigen. Because the protective properties of active immunization with OspC, and the fact that OspC expression is upregulated on the borrelial surface during tick feeding (11), have been well documented it is logical that a MAb generated by antigen inoculation via the natural route of tick bites would mirror the protective ability of the immunogen. Unexplained differences in the therapeutic effects of passively transferred and actively induced anti-OspC antibodies have been observed (13, 14). This MAb could be used to examine whether recognition of different epitopes is required for protection versus therapeutic clearance of infection.


    ACKNOWLEDGMENTS

We gratefully acknowledge the contributions of Rendi Murphree, Sarah Sullivan, and Steve Sviat. We express our thanks to Marc Dolan and Joe Piesman for providing ticks.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1671. Phone: (970) 491-1607. Fax: (970) 491-0603. E-mail: lmbow{at}lamar.colostate.edu.

Editor:   R. N. Moore


    REFERENCES
Top
Abstract
Text
References

1. Bockenstedt, L. K., E. Hodzic, S. Feng, K. W. Bourrel, A. de Silva, R. R. Montgomery, E. Fikrig, J. D. Radolf, and S. W. Barthold. 1997. Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect. Immun. 65:4661-4667[Abstract].
2. de Silva, A. M., S. R. Telford III, L. R. Brunet, S. W. Barthold, and E. Fikrig. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183:271-275[Abstract/Free Full Text].
3. Fikrig, E., S. R. Telford III, S. W. Barthold, F. S. Kantor, A. Spielman, and R. A. Flavell. 1992. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc. Natl. Acad. Sci. USA 89:5418-5421[Abstract/Free Full Text].
4. Gilmore, R. D., Jr., K. J. Kappel, M. C. Dolan, T. R. Burkot, and B. J. Johnson. 1996. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect. Immun. 64:2234-2239[Abstract].
5. Gilmore, R. D., Jr., and M. L. Mbow. 1998. A monoclonal antibody generated by antigen inoculation via tick bite is reactive to the Borrelia burgdorferi Rev protein, a member of the 2.9 gene family locus. Infect. Immun. 66:980-986[Abstract/Free Full Text].
6. Hughes, C. A., S. M. Engstrom, L. A. Coleman, C. B. Kodner, and R. C. Johnson. 1993. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Infect. Immun. 61:5115-5122[Abstract/Free Full Text].
7. Kurtti, T. J., U. G. Munderloh, C. A. Hughes, S. M. Engstrom, and R. C. Johnson. 1996. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins. Infect. Immun. 64:4148-4153[Abstract].
8. Piesman, J. 1993. Standard system for infecting ticks (Acari: Ixodidae) with the Lyme disease spirochete, Borrelia burgdorferi. J. Med. Entomol. 30:199-203[Medline].
9. Preac-Mursic, V., B. Wilske, E. Patsouris, S. Jauris, G. Will, E. Soutschek, S. Rainhardt, G. Lehnert, U. Klockmann, and P. Mehraein. 1992. Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection. Infection 20:342-349[Medline].
10. Probert, W. S., and R. B. LeFebvre. 1994. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen. Infect. Immun. 62:1920-1926[Abstract/Free Full Text].
11. Schwan, T. G., J. Piesman, W. T. Golde, M. C. Dolan, and P. A. Rosa. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 92:2909-2913[Abstract/Free Full Text].
12. Sinsky, R. J., and J. Piesman. 1989. Ear punch biopsy method for detection and isolation of Borrelia burgdorferi from rodents. J. Clin. Microbiol. 27:1723-1727[Abstract/Free Full Text].
13. Zhong, W., L. Gern, T. Stehle, C. Museteanu, M. Kramer, R. Wallich, and M. M. Simon. 1999. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur. J. Immunol. 29:946-957[Medline].
14. Zhong, W., T. Stehle, C. Museteanu, A. Siebers, L. Gern, M. Kramer, R. Wallich, and M. M. Simon. 1997. Therapeutic passive vaccination against chronic Lyme disease in mice. Proc. Natl. Acad. Sci. USA 94:12533-12538[Abstract/Free Full Text].

Infection and Immunity, October 1999, p. 5470-5472, Vol. 67, No. 10
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Embers, M. E., Alvarez, X., Ooms, T., Philipp, M. T. (2008). The Failure of Immune Response Evasion by Linear Plasmid 28-1-Deficient Borrelia burgdorferi Is Attributable to Persistent Expression of an Outer Surface Protein. Infect. Immun. 76: 3984-3991 [Abstract] [Full Text]  
  • Pal, U., Wang, P., Bao, F., Yang, X., Samanta, S., Schoen, R., Wormser, G. P., Schwartz, I., Fikrig, E. (2008). Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. JEM 205: 133-141 [Abstract] [Full Text]  
  • Gautam, A., Hathaway, M., McClain, N., Ramesh, G., Ramamoorthy, R. (2008). Analysis of the determinants of bba64 (P35) gene expression in Borrelia burgdorferi using a gfp reporter. Microbiology 154: 275-285 [Abstract] [Full Text]  
  • Bykowski, T., Woodman, M. E., Cooley, A. E., Brissette, C. A., Brade, V., Wallich, R., Kraiczy, P., Stevenson, B. (2007). Coordinated Expression of Borrelia burgdorferi Complement Regulator-Acquiring Surface Proteins during the Lyme Disease Spirochete's Mammal-Tick Infection Cycle. Infect. Immun. 75: 4227-4236 [Abstract] [Full Text]  
  • Buckles, E. L., Earnhart, C. G., Marconi, R. T. (2006). Analysis of Antibody Response in Humans to the Type A OspC Loop 5 Domain and Assessment of the Potential Utility of the Loop 5 Epitope in Lyme Disease Vaccine Development. CVI 13: 1162-1165 [Abstract] [Full Text]  
  • Xu, Q., Seemanapalli, S. V., McShan, K., Liang, F. T. (2006). Constitutive Expression of Outer Surface Protein C Diminishes the Ability of Borrelia burgdorferi To Evade Specific Humoral Immunity. Infect. Immun. 74: 5177-5184 [Abstract] [Full Text]  
  • Barthold, S. W., Hodzic, E., Tunev, S., Feng, S. (2006). Antibody-mediated disease remission in the mouse model of lyme borreliosis.. Infect. Immun. 74: 4817-4825 [Abstract] [Full Text]  
  • Skamel, C., Ploss, M., Bottcher, B., Stehle, T., Wallich, R., Simon, M. M., Nassal, M. (2006). Hepatitis B Virus Capsid-like Particles Can Display the Complete, Dimeric Outer Surface Protein C and Stimulate Production of Protective Antibody Responses against Borrelia burgdorferi Infection. J. Biol. Chem. 281: 17474-17481 [Abstract] [Full Text]  
  • Cluss, R. G., Silverman, D. A., Stafford, T. R. (2004). Extracellular Secretion of the Borrelia burgdorferi Oms28 Porin and Bgp, a Glycosaminoglycan Binding Protein. Infect. Immun. 72: 6279-6286 [Abstract] [Full Text]  
  • Liang, F. T., Yan, J., Mbow, M. L., Sviat, S. L., Gilmore, R. D., Mamula, M., Fikrig, E. (2004). Borrelia burgdorferi Changes Its Surface Antigenic Expression in Response to Host Immune Responses. Infect. Immun. 72: 5759-5767 [Abstract] [Full Text]  
  • Grimm, D., Tilly, K., Byram, R., Stewart, P. E., Krum, J. G., Bueschel, D. M., Schwan, T. G., Policastro, P. F., Elias, A. F., Rosa, P. A. (2004). Outer-surface protein C of the Lyme disease spirochete: A protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci. USA 101: 3142-3147 [Abstract] [Full Text]  
  • Miller, J. C., von Lackum, K., Babb, K., McAlister, J. D., Stevenson, B. (2003). Temporal Analysis of Borrelia burgdorferi Erp Protein Expression throughout the Mammal-Tick Infectious Cycle. Infect. Immun. 71: 6943-6952 [Abstract] [Full Text]  
  • Gilmore, R. D. Jr, Bacon, R. M., Carpio, A. M., Piesman, J., Dolan, M. C., Mbow, M. L. (2003). Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi. J Med Microbiol 52: 551-556 [Abstract] [Full Text]  
  • El-Hage, N., Stevenson, B. (2002). Simultaneous Coexpression of Borrelia burgdorferi Erp Proteins Occurs through a Specific, erp Locus-Directed Regulatory Mechanism. J. Bacteriol. 184: 4536-4543 [Abstract] [Full Text]  
  • Stevenson, B., Babb, K. (2002). LuxS-Mediated Quorum Sensing in Borrelia burgdorferi, the Lyme Disease Spirochete. Infect. Immun. 70: 4099-4105 [Abstract] [Full Text]  
  • Liang, F. T., Jacobs, M. B., Bowers, L. C., Philipp, M. T. (2002). An Immune Evasion Mechanism for Spirochetal Persistence in Lyme Borreliosis. JEM 195: 415-422 [Abstract] [Full Text]  
  • Carroll, J. A., El-Hage, N., Miller, J. C., Babb, K., Stevenson, B. (2001). Borrelia burgdorferi RevA Antigen Is a Surface-Exposed Outer Membrane Protein Whose Expression Is Regulated in Response to Environmental Temperature and pH. Infect. Immun. 69: 5286-5293 [Abstract] [Full Text]  
  • Babb, K., El-Hage, N., Miller, J. C., Carroll, J. A., Stevenson, B. (2001). Distinct Regulatory Pathways Control Expression of Borrelia burgdorferi Infection-Associated OspC and Erp Surface Proteins. Infect. Immun. 69: 4146-4153 [Abstract] [Full Text]  
  • Mbow, M. L., Zeidner, N., Gilmore, R. D. Jr., Dolan, M., Piesman, J., Titus, R. G. (2001). Major Histocompatibility Complex Class II-Independent Generation of Neutralizing Antibodies against T-Cell-Dependent Borrelia burgdorferi Antigens Presented by Dendritic Cells: Regulation by NK and {gamma}{delta} T Cells. Infect. Immun. 69: 2407-2415 [Abstract] [Full Text]  
  • El-Hage, N., Babb, K., Carroll, J. A., Lindstrom, N., Fischer, E. R., Miller, J. C., Gilmore, R. D. Jr, Mbow, M. L., Stevenson, B. (2001). Surface exposure and protease insensitivity of Borrelia burgdorferi Erp (OspEF-related) lipoproteins. Microbiology 147: 821-830 [Abstract] [Full Text]  
  • Pachner, A. R., Amemiya, K., Bartlett, M., Schaefer, H., Reddy, K., Zhang, W.-F. (2001). Lyme Borreliosis in Rhesus Macaques: Effects of Corticosteroids on Spirochetal Load and Isotype Switching of Anti-Borrelia burgdorferi Antibody. CVI 8: 225-232 [Abstract] [Full Text]  
  • Ohnishi, J., Piesman, J., de Silva, A. M. (2001). Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc. Natl. Acad. Sci. USA 98: 670-675 [Abstract] [Full Text]  
  • Shang, E. S., Champion, C. I., Wu, X.-Y., Skare, J. T., Blanco, D. R., Miller, J. N., Lovett, M. A. (2000). Comparison of Protection in Rabbits against Host-Adapted and Cultivated Borrelia burgdorferi following Infection-Derived Immunity or Immunization with Outer Membrane Vesicles or Outer Surface Protein A. Infect. Immun. 68: 4189-4199 [Abstract] [Full Text]  
  • Exner, M. M., Wu, X., Blanco, D. R., Miller, J. N., Lovett, M. A. (2000). Protection Elicited by Native Outer Membrane Protein Oms66 (p66) against Host-Adapted Borrelia burgdorferi: Conformational Nature of Bactericidal Epitopes. Infect. Immun. 68: 2647-2654 [Abstract] [Full Text]  
  • Gilmore, R. D. Jr., Piesman, J. (2000). Inhibition of Borrelia burgdorferi Migration from the Midgut to the Salivary Glands following Feeding by Ticks on OspC-Immunized Mice. Infect. Immun. 68: 411-414 [Abstract] [Full Text]  
  • Schwan, T. G., Piesman, J. (2000). Temporal Changes in Outer Surface Proteins A and C of the Lyme Disease-Associated Spirochete, Borrelia burgdorferi, during the Chain of Infection in Ticks and Mice. J. Clin. Microbiol. 38: 382-388 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mbow, M. L.
Right arrow Articles by Titus, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mbow, M. L.
Right arrow Articles by Titus, R. G.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»